Cas:41060-16-6 Panicolin manufacturer & supplier

We serve Chemical Name:Panicolin CAS:41060-16-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Panicolin

Chemical Name:Panicolin
CAS.NO:41060-16-6
Synonyms:SKULLCAPFLAVONE I;5-Hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-4H-chromen-4-one;4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy-;Panicolin
Molecular Formula:C17H14O6
Molecular Weight:314.289
HS Code:2914509090

Physical and Chemical Properties:
Melting point:254-256℃
Boiling point:573.6±50.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.646
PSA:89.13000
Exact Mass:314.079041
LogP:2.06

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like SKULLCAPFLAVONE I chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Panicolin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxyphenyl)-7,8-dimethoxy- Use and application,SKULLCAPFLAVONE I technical grade,usp/ep/jp grade.


Related News: What’s the background? Panicolin manufacturer Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. Panicolin supplier ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� Panicolin vendor To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. Panicolin factory What’s the background?